4.7 Article

Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Homologous PB1 gene promotes the replication efficiency of avian influenza H7N4 candidate vaccine virus

Liqi Liu et al.

Summary: The development of a suitable H7N4 candidate vaccine virus (CVV) for potential pandemic preparedness is crucial. Researchers constructed a reassortant virus with a (6 + 2) genome composition and introduced the polymerase basic protein 1 (PB1) to develop a (5 + 3) reassortant virus. The (5 + 3) virus exhibited improved growth characteristics and higher polymerase activity, and showed low pathogenicity in chickens and ferrets.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Article Microbiology

Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding

Rachael Dempsey et al.

Summary: Mutating the haemagglutinin protein of the influenza vaccine strain can enhance its replication in human cells and improve vaccine effectiveness. This improvement is achieved by overcoming inter-strain competition and increasing immunogenicity. The study suggests that enhanced binding to human receptors is the mechanism behind this improvement.

PLOS PATHOGENS (2022)

Article Virology

Optimization of A(H1N1)pdm09 vaccine seed viruses: The source of PB1 and HA vRNA as a major determinant for antigen yield

Filipe Almeida et al.

Summary: This study investigates the incorporation of polymerase basic protein 1 (PB1) viral RNA (vRNA) in influenza A virus and its potential impact on antigenicity and immunogenicity. The findings suggest that the presence of PB1 and its interaction with antigenic proteins can improve the hemagglutination capacity and neuraminidase activity of the virus. The study also highlights the importance of vRNA-vRNA interactions in determining the composition of the progeny. Further understanding of these interactions can contribute to the formulation of more effective influenza vaccines.

VIRUS RESEARCH (2022)

Article Infectious Diseases

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?

John Paget et al.

Summary: Since March 2020, the circulation of B/Yamagata-lineage in two influenza B virus lineages has not been confirmed. The WHO FluNet database reported detections of B/Yamagata-lineage in 2021 and 2022, but these detections could be due to the use of quadrivalent live-attenuated vaccines. All type B viruses detected after March 2020 belonged to the B/Victoria-lineage. There is a global need for efforts to detect and attribute lineage to type B influenza viruses, in order to assess if B/Yamagata-lineage viruses have become extinct.

EUROSURVEILLANCE (2022)

Article Medicine, General & Internal

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

A. Danielle Iuliano et al.

LANCET (2018)

Article Virology

CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus

Madina Mahesutihan et al.

VIROLOGICA SINICA (2018)

Article Multidisciplinary Sciences

Development of high-yield influenza B virus vaccine viruses

Jihui Ping et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Infectious Diseases

Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs

Callie Ridenour et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2015)

Article Multidisciplinary Sciences

Development of high-yield influenza A virus vaccine viruses

Jihui Ping et al.

NATURE COMMUNICATIONS (2015)

Article Infectious Diseases

Composition of Hemagglutinin and Neuraminidase Affects the Antigen Yield of Influenza A(H1N1)pdm09 Candidate Vaccine Viruses

Masayuki Shirakura et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2013)

Article Immunology

The development of vaccine viruses against pandemic A(H1N1) influenza

James S. Robertson et al.

VACCINE (2011)

Article Virology

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic

Andrew J. Broadbent et al.

CURRENT OPINION IN VIROLOGY (2011)

Review Medicine, General & Internal

CURRENT CONCEPTS Influenza Vaccines for the Future

Linda C. Lambert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Editorial Material Medicine, General & Internal

Reflections on Pandemic (H1N1) 2009 and the International Response

Gabriel M. Leung et al.

PLOS MEDICINE (2010)